N2-iBu-2’,3’-bis-O-TBDMS guanosine manufacturers
|
| | N2-iBu-2’,3’-bis-O-TBDMS guanosine Basic information |
| Product Name: | N2-iBu-2’,3’-bis-O-TBDMS guanosine | | Synonyms: | N2-iBu-2’,3’-bis-O-TBDMS guanosine;Guanosine, 2',3'-bis-O-[(1,1-dimethylethyl)dimethylsilyl]-N-(2-methyl-1-oxopropyl)- (9CI);2',3'-di-O-TBDMS-N2-ibu-Guanosine | | CAS: | 79974-70-2 | | MF: | C26H47N5O6Si2 | | MW: | 581.85 | | EINECS: | | | Product Categories: | | | Mol File: | 79974-70-2.mol |  |
| | N2-iBu-2’,3’-bis-O-TBDMS guanosine Chemical Properties |
| density | 1.20±0.1 g/cm3(Predicted) | | pka | 9.16±0.20(Predicted) |
| | N2-iBu-2’,3’-bis-O-TBDMS guanosine Usage And Synthesis |
| Uses | N2-iBu-2’,3’-bis-O-TBDMS guanosine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. | | References | [1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005 |
| | N2-iBu-2’,3’-bis-O-TBDMS guanosine Preparation Products And Raw materials |
|